ninlaro
takeda pharma a/s - ixazomib citrate - multiple myeloma - antineoplastic agents - ninlaro in combination with lenalidomide and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
ninlaro capsule
takeda canada inc - ixazomib (ixazomib citrate) - capsule - 2.3mg - ixazomib (ixazomib citrate) 2.3mg - antineoplastic agents
ninlaro capsule
takeda canada inc - ixazomib (ixazomib citrate) - capsule - 3mg - ixazomib (ixazomib citrate) 3mg - antineoplastic agents
ninlaro capsule
takeda canada inc - ixazomib (ixazomib citrate) - capsule - 4mg - ixazomib (ixazomib citrate) 4mg - antineoplastic agents